HealthLeaders-InterStudy, the leading provider of managed care market intelligence, reports that although many of the largest Blue Cross and Blue Shield-branded managed care organizations collectively lost more than half a million members between January 2008 and July 2008, Blue Shield of California bucks this trend.

HealthLeaders-InterStudy had previously issued a press release indicating that Blue Shield of California was losing lives in the first half of 2008, but in fact, Blue Shield of California gained almost 70,000 lives based on the time period January 2008 to July 2008. HealthLeaders-InterStudy regrets the error and is available to reporters to discuss Blue Shield of California's enrollment increase.

Enrollment data in Managed Market Surveyor-Rx describes plan and funding type including commercial lives (HMO, PPO, consumer-driven), Medicaid/Medicare and fully/self-insured.

Why Pharmaceutical Companies Need Managed Market Surveyor-Rx

Managed Market Surveyor-Rx delivers medical and pharmacy benefit enrollment data by managed care organization and geography (national, state, MSA) to better inform strategic planning and resource allocation. Relying on primary research and HealthLeaders-InterStudy's proprietary validation methodology, Managed Market Surveyor-Rx provides the most accurate managed care database available.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Lisa Osgood                                    Elizabeth Marshall   HealthLeaders-InterStudy                       Decision Resources, Inc.   781-296-2606                                   781-296-2563   losgood@hl-isy.com                             emarshall@dresources.com 

First Call Analyst:
FCMN Contact:

SOURCE: HealthLeaders-InterStudy

CONTACT: Lisa Osgood of HealthLeaders-InterStudy, +1-781-296-2606,
losgood@hl-isy.com; or Elizabeth Marshall of Decision Resources, Inc.,
+1-781-296-2563, emarshall@dresources.com

The Launch and Uptake of More Than 20 Novel Drugs Over The Next 10 Years Will Drive $12.5 Billion Growth in the Type 2 Diabetes Market

View Now